Dr. Nuh Rahbari received his medical degree from the Technical University of Munich, Germany in 2006. He commenced his surgical residency at the Universityhospital Heidelberg, Germany and joined the Edwin L. Steele Laboratories for Tumor Biology, Harvard Medical School and Massachusetts General Hospital, Boston, USA for a postdoctoral research fellowship from 2011-2013.
After completion of his surgical training, he was appointed faculty and director of the Clinical trial Unit at the Department of Surgery, Universityhospital Dresden in 2015. From 2016-2017 he did a fellowship in Surgical Oncology at Memorial Sloan-Kettering Cancer Center, New York, USA. In 2018, Dr. Rahbari joined the Department of Surgery, Universitymedicine Mannheim, University of Heidelberg, Mannheim, Germany, where he serves as Vice Chairman and Chief of the hepatobiliary and pancreatic surgery (HPB) service.
Dr. Rahbari’s has published extensively in the field of surgical oncology. His research focusses on the mechanisms of disease progression and the multi-disciplinary treatment of primary and secondary hepatic malignancies. He serves as a reviewer for several federal funding agencies as well as scientific journals and has initiated multiple clinical trials in the field of metastatic colorectal cancer, hepatic and pancreatic surgery.

The under construction